Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannovia is a U.S.-based consumer cannabis wellness company that sells hemp-derived CBD and Delta-9 THC products directly to consumers online. The company markets science-backed formulations for sleep, stress, pain, recovery, mood, energy, and pet wellness, and emphasizes U.S.-grown hemp, third-party testing, solvent-free extraction, and GMP manufacturing. Its portfolio includes oils, gummies, topicals, drink mixes, and pet products, with branded offerings such as GOODNIGHT, WAKE UP, Harmony THC+CBD Gummies, Odyssey gummies, and CBD Relief Foam. Cannovia positions itself as a family-founded, physician-backed brand using proprietary extraction and nano-ionization technologies to improve cannabinoid bioavailability and preserve whole-spectrum hemp compounds. This is a commercial-stage cannabinoid wellness business rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannovia.